Signal transduction pathways of IL-1β-mediated iNOS in pulmonary vascular smooth muscle cells

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 281, Issue 4 25-4, 2001, Pages

  Finder, Jonathan D ^a,d   Petrus, Jennifer L ^a   Hamilton, Andrew ^b   Villavicencio, Raphael T ^a   Pitt, Bruce R ^a   Sebti, Saïd M ^c  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY   (United States)

^c H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^d CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

Inducible nitric oxide synthase; Interleukin 1 ; Mitogen activated protein kinase; Rho

Indexed keywords

ADENOSINE DIPHOSPHATE RIBOSE; BACTERIAL ENZYME; EXOENZYME C3; GERANYLTRANSFERASE; GERANYLTRANSFERASE INHIBITOR; GUANINE NUCLEOTIDE BINDING PROTEIN; INTERLEUKIN 1BETA; JANUS KINASE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; NITRIC OXIDE SYNTHASE; PROTEIN C JUN; RAC PROTEIN; RAC1 PROTEIN; RHO FACTOR; STAT PROTEIN; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; UNCLASSIFIED DRUG;

ADENOSINE DIPHOSPHATE RIBOSYLATION; ANIMAL CELL; ARTICLE; CLOSTRIDIUM BOTULINUM; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME REGULATION; GENE OVEREXPRESSION; LUNG ALVEOLUS CELL; MALE; MEDIATOR RELEASE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PULMONARY ARTERY; RAT; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

EID: 0034791176     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.2001.281.4.l816     Document Type: Article

References (47)

1. Specific inhibitors of p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways block inducible nitric oxide synthase and tumor necrosis factor accumulation in murine macrophages stimulated with lipopolysaccharide and interferon-gamma
2. SB 203580 inhibits p38 mitogen-activated protein kinase, nitric oxide production, and inducible nitric oxide synthase in bovine cartilage-derived chondrocytes
3. Induction of cyclooxygenase-2 expression in human myometrial smooth muscle cells by interleukin-1beta: Involvement of p38 mitogen-activated protein kinase
4. Cytokine induction of inducible nitric oxide synthase in an oligodendrocyte cell line: Role of p38 mitogen-activated protein kinase activation
5. Extracellular signal-regulated kinase and p38 subgroups of mitogen-activated protein kinases regulate inducible nitric oxide synthase and tumor necrosis factor-alpha gene expression in endotoxin-stimulated primary glial cultures
6. Prenyltransferase inhibitors block superoxide production by pulmonary vascular smooth muscle
7. IL-1β stimulates superoxide and delayed peroxynitrite production by pulmonary vascular smooth muscle cells
8. The role of STATs in transcriptional control and their impact on cellular function
9. IRAK: A kinase associated with the interleukin-1 receptor
10. Identification of two distinct mechanisms of phagocytosis controlled by different Rho GTPases
11. Differential regulation by the mitogen-activated protein kinases in the expression of iNOS-NO by lipoarabinomannan
12. Association of STATs with relatives and friends
13. p38 but not p44/42 mitogen-activated protein kinase is required for nitric oxide synthase induction mediated by lipopolysaccharide in RAW 264.7 macrophages
14. Blockade of p38 mitogen-activated protein kinase pathway inhibits inducible nitric-oxide synthase expression in mouse astrocytes
15. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei
16. Inhibition of protein geranylgeranylation causes a superinduction of nitric-oxide synthase-2 by interleukin-1beta in vascular smooth muscle cells
17. p38 mitogen-activated protein kinase down-regulates nitric oxide and up-regulates prostaglandin E2 biosynthesis stimulated by interleukin-1beta
18. Both p38alpha(MAPK) and JNK/SAPK pathways are important for induction of nitric-oxide synthase by interleukin-1beta in rat glomerular mesangial cells
19. Inhibition of small G proteins of the rho family by statins or Clostridium difficile toxin B enhances cytokine-mediated induction of NO synthase II
20. A role for p38(MAPK)/HSP27 pathway in smooth muscle cell migration
21. Prolonged STAT1 activation is associated with interferon-gamma priming for interleukin-1-induced inducible nitric-oxide synthase expression by islets of Langerhans
22. Pulmonary arterial smooth muscle cells modulate cytokine- and LPS-induced cytotoxicity in endothelial cells
23. Cytokine induction of NO synthase II in human DLD-1 cells: Roles of the JAK-STAT, AP-1 and NF-kappaB-signaling pathways
24. Interleukin-1beta regulation of inducible nitric oxide synthase and cyclooxygenase-2 involves the p42/44 and p38 MAPK signaling pathways in cardiac myocytes
25. Role of ERK MAP kinases in responses of cultured human airway smooth muscle cells to IL-1β
26. Interleukin-1beta-induced rat pancreatic islet nitric oxide synthesis requires both the p38 and extracellular signal-regulated kinase 1/2 mitogen-activated protein kinases
27. Post-transcriptional regulation of endothelial nitric oxide synthase mRNA stability by Rho GTPase
28. Evidence for Rho-mediated agonist stimulation of phospholipase D in rat1 fibroblasts. Effects of Clostridium botulinum C3 exoenzyme
29. Inhibition by the JAK/STAT pathway of IFNgamma- and LPS-stimulated nitric oxide synthase induction in vascular smooth muscle cells
30. Regulation of interleukin-1beta-induced interleukin-6 gene expression in human fibroblast-like synoviocytes by p38 mitogen-activated protein kinase
31. Interleukin-1beta activates a short STAT-3 isoform in clonal insulin-secreting cells
32. Inhibition of Rho protein stimulates iNOS expression in rat vascular smooth muscle cells
33. Cytokines and lipopolysaccharide induce nitric oxide synthase in cultured rat pulmonary artery smooth muscle
34. Activation of Stat1 and subsequent transcription of inducible nitric oxide synthase gene in C6 glioma cells is independent of interferon-gamma-induced MAPK activation that is mediated by p21ras
35. Signal transduction pathways activated by the IL-1 receptor family: Ancient signaling machinery in mammals, insects, and plants
36. Design and synthesis of non-peptide Ras CAAX mimetics as potent farnesyltransferase inhibitors
37. Inhibitors of prenyl transferases
38. Cytosolic domain of the type I interleukin-1 receptor spontaneously recruits signaling molecules to activate a proinflammatory gene
39. The IL-1 receptor and Rho directly associate to drive cell activation and inflammation
40. Inhibiting geranylgeranylation blocks growth and promotes apoptosis in pulmonary vascular smooth muscle cells
41. Antitumor efficacy of a novel class of non-thiol-containing peptidomimetic inhibitors of farnesyltransferase and geranylgeranyltransferase I: Combination therapy with the cytotoxic agents cisplatin, Taxol, and gemcitabine
42. Cerivastatin suppresses lipopolysaccharide-induced ICAM-1 expression through inhibition of Rho GTPase in BAEC
43. Nitric oxide produced by cytokine-activated pulmonary artery smooth muscle cells is cytotoxic to cocultured endothelium
44. A novel STAT-like factor mediates lipopolysaccharide, interleukin 1 (IL-1), and IL-6 signaling and recognizes a gamma interferon activation site-like element in the IL1B gene
45. Potent, highly selective, and non-thiol inhibitors of protein geranylgeranyltransferase-I
46. The SIF binding element confers sis/PDGF inducibility onto the c-fos promoter
47. Transcriptional regulation of iNOS by IL-1β in cultured rat pulmonary artery smooth muscle cells